Though CVB3 vaccine can inhibit CVB3B3myocarditis, but it needs mass viral antigen while preparing, so the cost is too high to popularize and use in a large amount.

Most important, the new technique enables the BCG vaccine, and potentially other bacterial and viral based vaccines, to be dried without the traditional problems associated with standard freezing.